Chemotherapy plus immunotherapy improves survival in patients with metastatic urothelial cancer

A clinical trial co-led by Mount Sinai researchers is the first to show that using chemotherapy with immunotherapy resulted in improved survival in patients with an advanced type of bladder cancer.

Ventyx axes development of TYK2 inhibitor following Phase 2 failure

Ventyx Biosciences is shelving a drug after a mid-stage miss and failure. The company was investigating VTX958, an allosteric TYK2 inhibitor, in patients with moderately

July 30, 2024

Zoster Vaccine Found Effective, Safe in Autoimmune Patients

WASHINGTON — Individuals with systemic lupus erythematosus (SLE) and multiple sclerosis (MS) had fewer herpes zoster (shingles) attacks if they had received the recombinant vaccine

November 18, 2024

Movano receives FDA nod for smart ring’s pulse oximeter feature

Dive Brief: Movano Health received 510(k) clearance for the pulse oximeter feature in its Eviemed smart ring, the company said Monday. The Food and Drug

December 3, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.